We’ve built a prototype of a tool that looks at hospital prescriptions dispensed in the community. We describe what we’ve built, how we’ve built it, and how you can help us make it better.
New IV paracetamol measure launched.
A celebration of two brilliant days bringing together 200 people from across the medicines data community, featuring keynotes, the first Bennett Prize, and OpenPrescribing’s 10th birthday.
We know everyone says they want feedback. But we actually mean it. We record every suggestion we receive, track it, and use it to improve OpenPrescribing Hospitals.
A look at how OpenPrescribing Hospitals can be used to look at warfarin and other vitamin K antagonist use in hospital trusts in England.
A look at how OpenPrescribing Hospitals can be used to look at direct oral anticoagulant use in hospital trusts in England.
A look at how OpenPrescribing Hospitals can be used to look at low molecular weight heparin anticoagulant use in hospital trusts in England.
Latest OpenPrescribing and OpenPrescribing Hospitals updates
It’s now possible to easily share Measures and results of custom analyses on OpenPrescribing Hospitals. Here’s how to do it.
New OpenPrescribing and OpenPrescribing Hospitals measure to support work to manage the discontinuation of insulin detemir.
We have two new measures available now for SGLT-2 inhibitors.
Stay updated with notifications of new OpenPrescribing Hospitals features and data releases.
This newsletter contains all the latest updates from OpenPrescribing
A look at how to run a multi-product analysis on OpenPrescribing Hospitals.
How to choose the most appropriate quantity type for custom analyses on OpenPrescribing Hospitals.
A look at how to use the summary tables produced in custom analyses on OpenPrescribing Hospitals.
How you can run custom analyses of variation in medicines issuing across NHS trusts, ICB, region and nationally.
A summary of our research letter highlighting continuing co-proxamol use, published in the British Journal of General Practice
A national medicines usage analysis for lithium in primary and secondary care in England
We’ve launched a new OpenPrescribing Hospitals ‘low value prescribing’ measure for lidocaine plasters.
Special edition OpenPrescribing newsletter introducing our new tool, OpenPrescribing Hospitals.
What are biosimilars, why are they of interest and why can we monitor usage with primary care data but not secondary care data?
A look at the new Product Lookup feature on OpenPrescribing Hospitals
What is a Defined Daily Dose, how can they calculated from the quantity reported in the Secondary Care Medicines Data, and why are they useful?
How the ATC can be used to classify medications and how DDs can be used to measure their usage.
What is ingredient quantity, how can it be calculated from the quantity reported in the Secondary Care Medicines Data, and why is it useful?
Brian MacKenna demonstrated OpenPrescribing Hospitals at the 2025 Clinical Pharmacy Congress last month. Here’s his thoughts on how it went.
What are unit doses, how can they be calculated from the quantity reported in the Secondary Care Medicines Data, and why are they useful?
A look at how quantity is measured in the Secondary Care Medicines Data
The new custom analysis feature on OpenPrescribing Hospitals.
How we can use OpenPrescribing Hospitals measures to look at use of low value medicines in hospitals.
How we highlight variation in hospital medicines usage in OpenPrescribing Hospitals Measures.
An introduction to a new measures tool in OpenPrescribing Hospital.
The way the Secondary Care Medicines Data is published has recently changed. This is why this is good news for OpenPrescribing Hospitals.
How we can make it easier to compare issuing quantities of different products within the Secondary Care Medicines Data by using the dictionary of medicines and devices to find more detailed product information.
A first look at the data within the Secondary Care Medicines Dataset.
We’ve made OpenPrescribing Hospitals platform to all with our first feature. Read more to see how you can access it.
A deeper dive into what stock control data is and how it impacts the way the SCMD is published
A brief description of the Secondary Care Medicines Dataset, the primary dataset used in OpenPrescribing Hospitals
An explanation of the Submission History feature on OpenPrescribing Hospitals
The third blog in the series: Organising Organisations. Here, we describe how consistent the data submitted by NHS Trusts to the Secondary Care Medicines Dataset is
The second blog in the series: Organising Organisations. Here, we describe how complete the data submitted by NHS Trusts to the Secondary Care Medicines Dataset is
The first blog in the series: Organising Organisations. Here, we describe which NHS Trusts are included in the Secondary Care Medicines Dataset and how they can be identified
We’re going to build OpenPrescribing for hospitals using openly available secondary care medicines data. Here we explain why and what you can expect.
We briefly summarise all the recent big and exciting developments in hospital medicines data.
